Bioprinting firm Organovo and L’Oreal have announced today that they have partnered to create 3D printed skin and non-prescription beauty and skin care products.
In the past Organovo has 3D printed organ tissues such as the recently unveiled kidney cells, and will now start writing 3D printing skin to which L’Oreal will own the exclusive rights to the models for use in its research and development and production of new skin care products for the 3D printed skin.
Although Organovo will still be able to market and sell its skin tissues for use in surgical transplants, as well as pharmaceutical testing and therapy. L’oreal will be able to use the skin to develop products although it does currently state :
“L’oreal no longer tests on animals any of its products or any of its ingredients, anywhere in the world. Nor does L’Oréal delegate this task to others.” although L’oreal does state that “an exception could only be made if regulatory authorities demanded it for safety or regulatory purposes.”
Lets hope that the new 3D printed skin allows them to test their products without the need to harm any animals in the future even if authorities demanded it for regulatory purposes.
“Organovo designs and creates multi-cellular, dynamic and functional human tissues for use in drug discovery and medical research. Our proprietary 3D bioprinting technology enables the creation of tissues that mimic key aspects of native tissues. Organovo’s tissues are made available through testing services, customized projects, partnerships, and eventual therapeutic applications.”
For more information on the new Organovo 3D printed skin jump over to the official Organovo website for details via the link below.